المصدر: Women's Health Weekly; 2/2/2024, p1283-1283, 1p

مصطلحات موضوعية: MTOR inhibitors, EVEROLIMUS, PATENT applications, COLON cancer, NANOPARTICLES, VASCULAR endothelial growth factors

المؤلفون: Liu, Hongfang, Yao, Yang, Zhang, Juan, Li, Jing

المصدر: Cancer Chemotherapy & Pharmacology; Jun2020, Vol. 85 Issue 6, p1079-1087, 9p

مصطلحات موضوعية: STOMACH cancer, EXTRACELLULAR signal-regulated kinases, BCL-2 proteins, MTOR inhibitors, CELL culture, ONCOLOGY

المؤلفون: Matthew H Kulke, Fang-Shu Ou, Donna Niedzwiecki, Lucas Huebner, Pamela Kunz, Hagen F Kennecke, Edward M Wolin, Jennifer A Chan, Eileen M O’Reilly, Jeffrey A Meyerhardt, Alan Venook

المصدر: Endocr Relat Cancer

مصطلحات موضوعية: Bevacizumab, Vascular Endothelial Growth Factor A, Cancer Research, Endocrinology, Oncology, Endocrinology, Diabetes and Metabolism, Antineoplastic Combined Chemotherapy Protocols, Humans, Neuroectodermal Tumors, Primitive, Everolimus, MTOR Inhibitors, Disease-Free Survival, Article

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45c8f541bceb5416e86071067671278fTest
https://doi.org/10.1530/erc-21-0239Test

المصدر: Cancer Vaccine Week; 9/11/2023, p87-87, 1p

مصطلحات موضوعية: NANOPARTICLES, MTOR inhibitors, EVEROLIMUS, PATENT applications, BLADDER cancer, PATENT offices, IMMUNE checkpoint proteins

المؤلفون: Camillo Porta, Gaetano Pezzicoli, Elisabetta Filoni, Angela Gernone, Laura Cosmai, Mimma Rizzo

المصدر: Cancer Management and Research

مصطلحات موضوعية: Oncology, Renal clear cell carcinoma, autophagy, medicine.medical_specialty, Everolimus, biology, business.industry, Autophagy, anti-angiogenics, Review, everolimus, Discovery and development of mTOR inhibitors, Temsirolimus, Clinical trial, Rapa-Link, Internal medicine, temsirolimus, medicine, biology.protein, business, Mechanistic target of rapamycin, PI3K/AKT/mTOR pathway, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0c6338df79a652c64c6e49638b7bbc5Test
https://doi.org/10.2147/cmar.s267220Test

المؤلفون: Nicoletta Ranallo, Andrea Prochoswski Iamurri, Flavia Foca, Chiara Liverani, Alessandro De Vita, Laura Mercatali, Chiara Calabrese, Chiara Spadazzi, Carlo Fabbri, Davide Cavaliere, Riccardo Galassi, Stefano Severi, Maddalena Sansovini, Andreas Tartaglia, Federica Pieri, Laura Crudi, David Bianchini, Domenico Barone, Giovanni Martinelli, Giovanni Luca Frassineti, Toni Ibrahim, Luana Calabrò, Rossana Berardi, Alberto Bongiovanni

المصدر: Cancers; Volume 14; Issue 13; Pages: 3231

مصطلحات موضوعية: NET, Cancer Research, body composition, mTOR inhibitors, Oncology, muscle tissue, everolimus, adipose tissue, neuroendocrine tumors, NO

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d190f9da312016b6ab8d85379cfe442bTest
https://pubmed.ncbi.nlm.nih.gov/35805003Test

المؤلفون: Tiffany Shaw, Hannah Lee, Robert A. Figlin

المصدر: ONCOLOGY. :306-310

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Cabozantinib, medicine.medical_treatment, Ipilimumab, chemistry.chemical_compound, Antineoplastic Agents, Immunological, Renal cell carcinoma, Internal medicine, Basic Helix-Loop-Helix Transcription Factors, medicine, Humans, Carcinoma, Renal Cell, Protein Kinase Inhibitors, Randomized Controlled Trials as Topic, Everolimus, business.industry, MTOR Inhibitors, Immunotherapy, medicine.disease, Kidney Neoplasms, respiratory tract diseases, Axitinib, chemistry, Practice Guidelines as Topic, Nivolumab, business, Lenvatinib, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2384827fee72ba75eb3766c87f599354Test
https://doi.org/10.46883/onc.2021.3506.0306Test

المؤلفون: Kulke, Matthew H, Ou, Fang-Shu, Niedzwiecki, Donna, Huebner, Lucas, Kunz, Pamela, Kennecke, Hagen F, Wolin, Edward M, Chan, Jennifer A, O'Reilly, Eileen M, Meyerhardt, Jeffrey A, Venook, Alan

المصدر: Articles, Abstracts, and Reports

مصطلحات موضوعية: oregon, chiles, Antineoplastic Combined Chemotherapy Protocols, Bevacizumab, Disease-Free Survival, Everolimus, Humans, MTOR Inhibitors, Neuroectodermal Tumors, Primitive, Vascular Endothelial Growth Factor A, Endocrinology, Diabetes, and Metabolism, Oncology

العلاقة: https://digitalcommons.psjhealth.org/publications/6100Test; https://pubmed.ncbi.nlm.nih.gov/35324465Test

الإتاحة: https://digitalcommons.psjhealth.org/publications/6100Test
https://pubmed.ncbi.nlm.nih.gov/35324465Test

المؤلفون: David Casadevall, Anna Hernández-Prat, Sara García-Alonso, Oriol Arpí-Llucià, Silvia Menéndez, Mengjuan Qin, Cristina Guardia, Beatriz Morancho, Francisco Javier Sánchez-Martín, Sandra Zazo, Elena Gavilán, Mohammad A. Sabbaghi, Pilar Eroles, Juan Miguel Cejalvo, Ana Lluch, Federico Rojo, Atanasio Pandiella, Ana Rovira, Joan Albanell

المساهمون: Instituto de Salud Carlos III, Generalitat de Catalunya, Ministerio de Economía y Competitividad (España), Fundación CRIS contra el Cáncer, China Scholarship Council, European Commission

المصدر: Digital.CSIC. Repositorio Institucional del CSIC
instname

مصطلحات موضوعية: musculoskeletal diseases, Inhibition of mTOR increases the antitumor activity of T-DM1, congenital, hereditary, and neonatal diseases and abnormalities, Cancer Research, Immunoconjugates, Receptor, ErbB-2, TOR Serine-Threonine Kinases, Breast Neoplasms, Mechanistic Target of Rapamycin Complex 1, Trastuzumab, Ado-Trastuzumab Emtansine, Antibodies, Monoclonal, Humanized, Antibody-drug conjugates warrants clinical evaluation in patients with HER2-positive breast cancer, Xenograft Model Antitumor Assays, Mice, Supporting that the combination of mTOR inhibitors, Oncology, Cell Line, Tumor, Animals, Humans, Female, Everolimus, skin and connective tissue diseases, Molecular Biology

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3656e1cb422ad1d2aa23e9ba81826192Test
http://hdl.handle.net/10261/282954Test

المؤلفون: Nicola Fusco, Antonio Ghidini, Gianluca Tomasello, Francesco Grossi, Fausto Petrelli, Andrea Botticelli, Michele Ghidini, Giulia Grizzi, Tommaso Savio, Mary Cabiddu

المصدر: Cancer Management and Research, Vol Volume 12, Pp 675-686 (2020)
Cancer Management and Research

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Estrogen receptor, Review, Palbociclib, lcsh:RC254-282, Aromatase inhibitors, Breast cancer, CDK 4/6 inhibitors, MTOR inhibitors, Neoadjuvant endocrine therapy, PI3K inhibitors, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, medicine, Abemaciclib, Everolimus, business.industry, Cancer, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, 030104 developmental biology, chemistry, 030220 oncology & carcinogenesis, Hormonal therapy, business, Tamoxifen, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1827d1c140e47f6f8a458a2962ff8f54Test
https://doi.org/10.2147/cmar.s202965Test